Page last updated: 2024-10-25

cilostazol and Autism Spectrum Disorder

cilostazol has been researched along with Autism Spectrum Disorder in 2 studies

Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)

Research Excerpts

ExcerptRelevanceReference
"We aimed to evaluate cilostazol therapeutic effects on aberrant behaviors of autism spectrum disorder (ASD) children and its safety profile in a double-blind, randomized clinical trial."9.69Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial. ( Akhondzadeh, S; Bagheri, S; Ebrahimi, P; Moeini, M; Mohammadi, MR; Moradi, K; Seyedmirzaei, H, 2023)
"The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety."8.02Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021)
"The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety."4.02Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Luhach, K1
Kulkarni, GT1
Singh, VP1
Sharma, B1
Ebrahimi, P1
Seyedmirzaei, H1
Moradi, K1
Bagheri, S1
Moeini, M1
Mohammadi, MR1
Akhondzadeh, S1

Trials

1 trial available for cilostazol and Autism Spectrum Disorder

ArticleYear
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial.
    International clinical psychopharmacology, 2023, 03-01, Volume: 38, Issue:2

    Topics: Antipsychotic Agents; Autism Spectrum Disorder; Child; Cilostazol; Double-Blind Method; Drug Therapy

2023

Other Studies

1 other study available for cilostazol and Autism Spectrum Disorder

ArticleYear
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    The Journal of pharmacy and pharmacology, 2021, Oct-07, Volume: 73, Issue:11

    Topics: Animals; Anticonvulsants; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Brain; Ci

2021